StockData
Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc. (SRTS) stock

SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3016% below fair value
$3.41+0.11 (+3.33%)

Close on Nov 11, 2026Market cap $56.14MP/E –Yield –

Sensus Healthcare, Inc. saw revenue fall 53.4% to $17.51M over the twelve months to Jun 30, 2026. Free cash flow was -$6.97M, down 299.6% from a year earlier. At the latest close the market valued the company at $56.14M.

Revenue
$17.51M
-53.4% vs. a year earlier
Operating income
-$13.26M
TTM Q2 2026
Free cash flow
-$6.97M
-299.6% vs. a year earlier
EPS, diluted
-$0.94
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$56.14M
P/E ratio
–
Price to sales
3.21
Price to book
1.52
Dividend yield
–
Free cash flow yield
-12.42%

Fundamentals

Revenue
$17.51M
Net income
-$15.49M
EPS, diluted
-$0.94
Free cash flow
-$6.97M
Book value per share
$2.24
Diluted shares
16M

Trading

Next earnings
Q3 FY2026, expected soon
Previous close
$3.30
Open
$3.35
Day's range
$3.23 – $3.53
Volume
69,154
Average volume (20 days)
559,164
Beta (5 years)
1.18
52-week range
$2.66 – $5.49
RSI (14 days)
64.4
Volatility (1 year)
64.4%
Relative volume
0.47×
WACC
10.8%

On 1 of our idea list: Stocking up

Market cap history

Month-end market cap since 2016, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodSRTSS&P 500DifferenceSRTS per yearS&P 500 per year
1 month+15.6%-2.4%+18.0 pts
3 months+10.0%-1.2%+11.2 pts
Year to date-14.3%+12.3%−26.6 pts
1 year-19.0%+12.4%−31.4 pts
3 years+79.5%+78.8%+0.7 pts+21.5%+21.4%
5 years-28.4%+75.2%−103.5 pts-6.5%+11.9%
10 years-43.6%+311.1%−354.7 pts-5.6%+15.2%

Twelve years at a glance

Fiscal years 2014 to 2025 and trailing twelve months, USD

Revenue

$17.51M-53.4% YoY

Gross profit

$6.37M-67.5% YoY

Operating income

-$13.26M

Net income

-$15.49M

EPS, diluted

-$0.94

Free cash flow

-$6.97M-299.6% YoY
Reported periodTrailing twelve months

Press releases

Releases Sensus Healthcare filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Sensus Healthcare

Surgical & Medical Instruments & Apparatus

Sensus Healthcare, Inc. is a medical device company that develops and markets non-invasive superficial radiation therapy systems for treating non-melanoma skin cancer and preventing keloid scars. Operating in a single business segment, the company provides the SRT-100, SRT-100+, and SRT-100 Vision treatment devices, along with clinical consumables. It also delivers maintenance through its Sentinel program, cloud software, and turn-key service agreements that include equipment, technologist staffing, and clinical oversight. Its primary customers include private dermatology practices and radiation oncologists.

Company profile, executives and history

Sensus Healthcare stock: common questions

What is Sensus Healthcare's stock price?

SRTS closed at $3.41 on Nov 11, 2026, up 3.33% on the day. Over the past 52 weeks it traded between $2.66 and $5.49.

What is Sensus Healthcare's market cap?

Sensus Healthcare was worth $56.14M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is SRTS's P/E ratio?

Sensus Healthcare lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.94), so it has no meaningful P/E ratio.

How much revenue does Sensus Healthcare make?

Sensus Healthcare reported revenue of $17.51M for the twelve months to Jun 30, 2026, down 53.4% from a year earlier.

Does Sensus Healthcare pay a dividend?

No. Sensus Healthcare has not paid a cash dividend over the last twelve months.

When does Sensus Healthcare report earnings next?

Sensus Healthcare's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.

How has SRTS stock performed over the past year?

Including dividends, SRTS returned -19.0% over the past year, against +12.4% for the S&P 500.

How many SRTS shares are sold short?

0M shares were sold short at the latest FINRA report, 1.56% of the float, or 7.2 days of average trading volume.

Who are Sensus Healthcare's competitors?

Companies most similar to Sensus Healthcare by business, industry and size include BDMD, PROF, SNOA, NSPR, BTCY.

See a number that looks wrong?